YMDD motif mutations in chronic hepatitis B antiviral treatment naïve patients: a multi-center study.

@article{Tan2012YMDDMM,
  title={YMDD motif mutations in chronic hepatitis B antiviral treatment na{\"i}ve patients: a multi-center study.},
  author={You-wen Tan and Guo-hong Ge and Wei Zhao and Jian-he Gan and Yun M. Zhao and Zhi-Lin Niu and Dong-Jun Zhang and Li Chen and Xue-jun Yu and Li-jun Yang},
  journal={The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases},
  year={2012},
  volume={16 3},
  pages={250-5}
}
OBJECTIVE This study aimed to determine the natural prevalence of variants of tyrosine-methionine-aspartic acid-aspartic acid (YMDD) motif in patients with chronic hepatitis B (CHB), and to explore its relation with demographic and clinical features, hepatitis B virus (HBV) genotypes, and HBV DNA levels. METHODS A total of 1,042 antiviral treatment naïve CHB patients (including with lamivudine [LAM]) in the past year were recruited from outpatient and inpatient departments of six centers from… CONTINUE READING
Highly Cited
This paper has 25 citations. REVIEW CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 32 references

Validation of the inno-LiPA HBV Dr assay (version 2) in monitoring hepatitis B virus-infected patients receiving nucleoside analog treatment

  • HG niesters, Zoulim f, Pichoud c
  • Antimicrob Agents chemother
  • 2010

DG. the spontaneous YMDD mutation rate in chronic hepatitis B patients

  • Min Xc, XH Miao, Zhao sM, KK Zhao, Yang
  • Zhonghua Gan Zang Bing Za Zhi
  • 2009

Similar Papers

Loading similar papers…